Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 111 (3) , 592-597
- https://doi.org/10.1067/mai.2003.114
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed SkinThe Journal of Experimental Medicine, 2001
- Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokinesJournal of Allergy and Clinical Immunology, 2001
- Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activityJournal of Allergy and Clinical Immunology, 2001
- Molecular cloning of a novel CC chemokine, interleukin‐11 receptor α‐locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virusFEBS Letters, 1999
- Soluble E-selectin as a marker of disease activity in atopic dermatitis☆, ☆☆, ★, ★★Journal of Allergy and Clinical Immunology, 1997
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993
- Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasisBritish Journal of Dermatology, 1988
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978